In conclusion, we have revealed ERK activity dynamics regulated by two distinct upstream receptors, EGFR and ErbB2, in the intestinal epithelium and shown that alterations in the dynamics caused by Wnt signalling activation underlie the high sensitivity of tumour cells to EGFR inhibition. Here, ERBB2 is linked to neoplasm.